344 related articles for article (PubMed ID: 31031659)
1. Sleep Disorders in Huntington's Disease.
Herzog-Krzywoszanska R; Krzywoszanski L
Front Psychiatry; 2019; 10():221. PubMed ID: 31031659
[TBL] [Abstract][Full Text] [Related]
2. Intensification of Diurnal Abnormal Movements During Sleep in Huntington's Disease.
Salaun L; Bonduelle T; Ghorayeb I; Spampinato U; Debruxelles S; Guehl D; Goizet C
J Huntingtons Dis; 2024; 13(2):259-262. PubMed ID: 38788081
[TBL] [Abstract][Full Text] [Related]
3. Circadian and sleep disorder in Huntington's disease.
Morton AJ
Exp Neurol; 2013 May; 243():34-44. PubMed ID: 23099415
[TBL] [Abstract][Full Text] [Related]
4. Circadian rhythm and autonomic dysfunction in presymptomatic and early Huntington's disease.
Bellosta Diago E; Pérez Pérez J; Santos Lasaosa S; Viloria Alebesque A; Martínez Horta S; Kulisevsky J; López Del Val J
Parkinsonism Relat Disord; 2017 Nov; 44():95-100. PubMed ID: 28935191
[TBL] [Abstract][Full Text] [Related]
5. Circadian-based Treatment Strategy Effective in the BACHD Mouse Model of Huntington's Disease.
Whittaker DS; Loh DH; Wang HB; Tahara Y; Kuljis D; Cutler T; Ghiani CA; Shibata S; Block GD; Colwell CS
J Biol Rhythms; 2018 Oct; 33(5):535-554. PubMed ID: 30084274
[TBL] [Abstract][Full Text] [Related]
6. Sleep Disorders and Circadian Disruption in Huntington's Disease.
Saade-Lemus S; Videnovic A
J Huntingtons Dis; 2023; 12(2):121-131. PubMed ID: 37424473
[TBL] [Abstract][Full Text] [Related]
7. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease.
Aziz NA; Anguelova GV; Marinus J; Lammers GJ; Roos RA
Parkinsonism Relat Disord; 2010 Jun; 16(5):345-50. PubMed ID: 20236854
[TBL] [Abstract][Full Text] [Related]
8. Sleep, Circadian Rhythms, and Cognitive Dysfunction in Huntington's Disease.
Fitzgerald ES; Stout JC; Glikmann-Johnston Y; Anderson C; Jackson ML
J Huntingtons Dis; 2023; 12(3):293-304. PubMed ID: 37599535
[TBL] [Abstract][Full Text] [Related]
9. Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington's Disease.
Wang HB; Loh DH; Whittaker DS; Cutler T; Howland D; Colwell CS
eNeuro; 2018; 5(1):. PubMed ID: 29302618
[TBL] [Abstract][Full Text] [Related]
10. Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington's disease.
Wang HB; Whittaker DS; Truong D; Mulji AK; Ghiani CA; Loh DH; Colwell CS
Neurobiol Sleep Circadian Rhythms; 2017 Jan; 2():39-52. PubMed ID: 31236494
[TBL] [Abstract][Full Text] [Related]
11. Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington's disease.
Bartlett DM; Domínguez D JF; Reyes A; Zaenker P; Feindel KW; Newton RU; Hannan AJ; Slater JA; Eastwood PR; Lazar AS; Ziman M; Cruickshank T
Neurobiol Sleep Circadian Rhythms; 2019 Jan; 6():1-8. PubMed ID: 31236517
[TBL] [Abstract][Full Text] [Related]
12. How vital is sleep in Huntington's disease?
Goodman AO; Barker RA
J Neurol; 2010 Jun; 257(6):882-97. PubMed ID: 20333394
[TBL] [Abstract][Full Text] [Related]
13. Circadian Rhythm, Cognition, and Mood Disorders in Huntington's Disease.
Diago EB; Martínez-Horta S; Lasaosa SS; Alebesque AV; Pérez-Pérez J; Kulisevsky J; Del Val JL
J Huntingtons Dis; 2018; 7(2):193-198. PubMed ID: 29843249
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington's disease: A nine-month pilot study.
Bartlett DM; Dominguez D JF; Lazar AS; Kordsachia CC; Rankin TJ; Lo J; Govus AD; Power BD; Lampit A; Eastwood PR; Ziman MR; Cruickshank TM
J Neurol Sci; 2020 Jan; 408():116522. PubMed ID: 31665619
[TBL] [Abstract][Full Text] [Related]
15. Early and progressive circadian abnormalities in Huntington's disease sheep are unmasked by social environment.
Morton AJ; Rudiger SR; Wood NI; Sawiak SJ; Brown GC; Mclaughlan CJ; Kuchel TR; Snell RG; Faull RL; Bawden CS
Hum Mol Genet; 2014 Jul; 23(13):3375-83. PubMed ID: 24488771
[TBL] [Abstract][Full Text] [Related]
16. Management of Huntington's disease: role of tetrabenazine.
de Tommaso M; Serpino C; Sciruicchio V
Ther Clin Risk Manag; 2011; 7():123-9. PubMed ID: 21479143
[TBL] [Abstract][Full Text] [Related]
17. Using Actiwatch to monitor circadian rhythm disturbance in Huntington' disease: A cautionary note.
Townhill J; Hughes AC; Thomas B; Busse ME; Price K; Dunnett SB; Hastings MH; Rosser AE
J Neurosci Methods; 2016 May; 265():13-8. PubMed ID: 26774754
[TBL] [Abstract][Full Text] [Related]
18. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington's disease.
Hurelbrink CB; Lewis SJ; Barker RA
J Neurol; 2005 Jun; 252(6):642-7. PubMed ID: 15742112
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease.
van Wamelen DJ; Roos RA; Aziz NA
Neurodegener Dis Manag; 2015 Dec; 5(6):549-59. PubMed ID: 26621387
[TBL] [Abstract][Full Text] [Related]
20. Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.
Kuljis D; Schroeder AM; Kudo T; Loh DH; Willison DL; Colwell CS
Minerva Pneumol; 2012 Sep; 51(3):93-106. PubMed ID: 23687390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
